Yahoo Web Search

Search results

    • Kane Biotech Announces First Quarter 2024 Financial Results

      Digital Journal· 1 day ago

      KANE BIOTECH INC. Selected Financial Results Consolidated Statements of Comprehensive LossThree months ended March 31, 2024 2023 Total revenue, continuing operations$51,886 $35,271 Gross profit, continuing operations 40,051 28,153